表紙
市場調查報告書

非外科的美容整形的全球市場:2017年∼2021年

Global Non-Surgical Cosmetic Surgery Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 507544
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
非外科的美容整形的全球市場:2017年∼2021年 Global Non-Surgical Cosmetic Surgery Market 2017-2021
出版日期: 2017年05月24日內容資訊: 英文 70 Pages
簡介

非外科的美容整形術中包含肉毒桿菌 (BTX) 、玻尿酸 (HA) 、果酸換膚,脫毛及微晶煥膚的使用。全球非外科的美容整形市場,從2017年到2021年的預測期間內,以7.87%的年複合成長率擴大。

本報告提供非外科的美容整形的全球市場調查,各治療方法、地區的市場規模分析、預測,市場推動因素與課題,市場趨勢,競爭情形和主要企業等系統性資訊。

第1章 摘要整理

第2章 調查範圍

第3章 調查手法

第4章 簡介

第5章 市場形勢

  • 市場概要
  • 市場規模、預測
  • 波特的五力分析

第6章 地區區分

  • 概要
  • 南北美洲
  • EMEA (歐洲、中東、非洲)
  • APAC (亞太地區)

第7章 市場區隔:各治療方法

  • 概要
  • BTX (肉毒桿菌)
  • HA (玻尿酸)
  • 其他

第8章 決策架構

第9章 推動市場要素與課題

  • 推動市場要素
  • 市場課題

第10章 市場趨勢

  • 選擇美容整形術的男性數的增加
  • 美容院的重要性高漲
  • 服務供應商數的增加
  • 醫療旅遊業的成長
  • 抗老化手段相關的認識高漲

第11章 業者情勢

  • 概要

第12章 主要供應商分析

  • ALLERGAN
  • Cynosure
  • Merz Pharma
  • Galderma
  • 其他有潛力的供應商

第13章 附錄

圖表清單

目錄
Product Code: IRTNTR12930

About Non-Surgical Cosmetic Surgery

Non-surgical cosmetic procedure involves the use of botulinum toxin (BTX), hyaluronic acid (HA), chemical peel, hair removal, and microdermabrasion. It is a non-invasive procedure that is performed by cosmetic or plastic surgeons. Non-surgical cosmetic procedures contribute a higher share of revenue to the global cosmetic procedures market when compared with surgical cosmetic procedures.

Technavio's analysts forecast the global non-surgical cosmetic surgery market to grow at a CAGR of 7.87% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global non-surgical cosmetic surgery market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Non-Surgical Cosmetic Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • ALLERGAN
  • Cynosure
  • Merz Pharma
  • Galderma

Other Prominent Vendors

  • Alma Lasers
  • AQTIS Medical
  • BTL
  • Cutera
  • Genesis Biosystems
  • HCbeauty
  • Hangzhou Techderm Biological Products
  • Lumenis
  • Medytox
  • Suneva Medical
  • SciVision Biotech
  • Speciality European Pharma
  • Sciton
  • VCA Laser
  • VisionMed

Market driver

  • Increasing spending on reconstructive treatment
  • For a full, detailed list, view our report

Market challenge

  • Proliferation of counterfeit products
  • For a full, detailed list, view our report

Market trend

  • Growing number of men opting for cosmetic treatment
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Overview

PART 05: Market landscape

  • Overview
  • Market size and forecast
  • Five forces analysis

PART 06: Geographical segmentation

  • Overview
  • Americas
  • EMEA
  • APAC

PART 07: Market segmentation by treatment procedure

  • Overview
  • BTX
  • HA
  • Others

PART 08: Decision framework

PART 09: Drivers and challenges

  • Market drivers
  • Market challenges

PART 10: Market trends

  • Growing number of men opting for cosmetic treatment
  • Growing importance of aesthetics
  • Increasing number of service providers
  • Growth of medical tourism
  • Increasing awareness about anti-aging measures

PART 11: Vendor landscape

  • Overview

PART 12: Key vendor analysis

  • ALLERGAN
  • Cynosure
  • Merz Pharma
  • Galderma
  • Other prominent vendors

PART 13: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global non-surgical cosmetic procedures market: Overview
  • Exhibit 02: Global cosmetic surgery market: Treatment procedures
  • Exhibit 03: Global non-surgical cosmetic procedures market 2016-2021 ($ billions)
  • Exhibit 04: Global non-surgical cosmetic procedures market: Impact of major factors
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Global non-surgical cosmetic procedures market: Segmentation by geography
  • Exhibit 07: Non-surgical cosmetic procedures market in Americas: Overview
  • Exhibit 08: Non-surgical cosmetic procedures market in Americas 2016-2021 ($ billions)
  • Exhibit 09: Non-surgical cosmetic procedures market in EMEA: Overview
  • Exhibit 10: Non-surgical cosmetic procedures market in EMEA 2016-2021 ($ billions)
  • Exhibit 11: Non-surgical cosmetic procedures market in APAC: Overview
  • Exhibit 12: Non-surgical cosmetic procedures market in APAC 2016-2021 ($ billions)
  • Exhibit 13: Global non-surgical cosmetic procedures market: Segmentation by treatment procedure
  • Exhibit 14: Global non-surgical BTX cosmetic procedures market 2016-2021 ($ billions)
  • Exhibit 15: Global non-surgical HA cosmetic procedures market 2016-2021 ($ billions)
  • Exhibit 16: Global other non-surgical cosmetic procedure market 2016-2021 ($ billions)
  • Exhibit 17: Population aged 65 and above 2006-2014 (% of total)
  • Exhibit 18: Top five cosmetic minimally invasive procedures of 2014
  • Exhibit 19: ALLERGAN: Overview
  • Exhibit 20: ALLERGAN: Strength analysis
  • Exhibit 21: ALLERGAN: Strategy assessment
  • Exhibit 22: ALLERGAN: Opportunity assessment
  • Exhibit 23: Cynosure: Overview
  • Exhibit 24: Cynosure: Strength analysis
  • Exhibit 25: Cynosure: Strategy assessment
  • Exhibit 26: Cynosure: Opportunity assessment
  • Exhibit 27: Merz Pharma: Overview
  • Exhibit 28: Merz Pharma: Strength analysis
  • Exhibit 29: Merz Pharma: Strategy assessment
  • Exhibit 30: Merz Pharma: Opportunity assessment
  • Exhibit 31: Galderma: Overview
  • Exhibit 32: Galderma: Strength analysis
  • Exhibit 33: Galderma: Strategy assessment
  • Exhibit 34: Galderma: Opportunity assessment